IFx-Hu2.0 Expanded Access Program
Expanded access requests for IFx-Hu2.0 may be considered for the treatment of adult patients
(greater than or equal to 18 years of age) with stage III through IV cutaneous melanoma,
advanced Merkel cell carcinoma (MCC), or advanced cutaneous squamous cell carcinoma (cSCC)
who have failed all available treatment options.
To request access, use Responsible Party contact information provided in this record.